These results were also corroborated by the serological analysis of sFRP1 in blood-samples of HCC patients of different stages, demonstrating higher level of sFRP1 in higher stage patients (Fig 6D) which included patients of stage 3a and above. The gene discussed is SFRP1; the disease is hepatocellular carcinoma.